The present invention relates to an optically pure quinazoline compound, especially the compound as represented by formula (I), and a pharmaceutical composition containing therapeutically effective amount of the compound. Also a use of the pharmaceutical composition for the preparation of a medicament for the treatment of diseases related to the modulation of c-erbB-2 and/or the activity of EGF-R protein tyrosine kinase.
展开▼
